Recent News

• 06.12.2026 - From Strategy to Approval: Case Studies in Advancing Clinical Programs for Emerging Biotech
• 06.11.2026 - Regulatory Strategy Leadership​
• 06.10.2026 - Albarah Al Afandi, MPharm
• 06.10.2026 - Albarah Al Afandi, MPharm
• 06.10.2026 - Catherine Laing
• 06.10.2026 - Catherine Laing
• 06.10.2026 - Dr Ben Monaghan
• 06.10.2026 - Dr Ben Monaghan
• 06.10.2026 - Dr Jon Ackroyd
• 06.10.2026 - Dr Jon Ackroyd

Recent Filings

• 06.10.2026 - 144 Report of proposed sale of securities
• 06.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.02.2026 - 144 Report of proposed sale of securities
• 06.02.2026 - 144 Report of proposed sale of securities
• 05.20.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.18.2026 - 144 Report of proposed sale of securities
• 05.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.05.2026 - 8-K Current report
• 05.05.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]